Susan Hasty, Publisher
Table of Contents . . . November 25th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis C Virus - Virus activates a protein sometimes linked to onset of cancer
Hepatitis Complications - Combination therapy appropriate for treating hepatitis C-related glomerulopathy
Epidemiology - Routine use of bleach to disinfect syringes may lower odds for hepatitis C
Hepatitis B Virus Vaccine - Postexposure hepatitis B vaccine not effective in hemodialysis patients
Hepatitis C Virus Research - Glucosidase inhibitors could augment interferon in chronic hepatitis C
Blood Safety - First platelet pathogen inactivation system receives CE clearance
Diagnostics - Ultra-sensitive test detects hepatitis B virus mutants
Drug Development - Update given for HIV, cystic fibrosis, and hepatitis drugs in clinical pipeline
Hepatitis C - Combination therapy effective for refractory hepatitis C infection
Hepatitis C - Vaccine blunts virus's sting
Hepatocellular Carcinoma - Antisense nucleotides keep cancer cell proliferation in check
Liver Cirrhosis - Patient randomization of Actimmune phase II trial completed
Patents - Final settlement of disputes involving Amdoxovir announced
Therapies (HCV) - FDA approves peginterferon alfa-2a for treatment
Vaccine Development - Collaboration extended on therapeutic vaccines for three oncogenic viruses
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.